Increasing Time Costs and Copayments for Prescription Drugs
June 1, 2011 | Journal Article
A decrease in prescription length and an increase in brand-name co-payment decreased medication adherence in North Carolina.
You are now viewing 1 - 10 of 10 results
June 1, 2011 | Journal Article
A decrease in prescription length and an increase in brand-name co-payment decreased medication adherence in North Carolina.
December 16, 2005 | Program Result
Between August 1999 and January 2002, Anthony T. Lo Sasso, Ph.D., and researchers at Northwestern University analyzed the extent to which co-payments for substance abuse treatment influenced people's utilization of treatment services.
November 1, 2010 | Journal Article
A large value-based insurance design program offered by Blue Cross Blue Shield of North Carolina eliminated generic medication copayments and reduced copayments for brand-name medications.
May 1, 2012 | Journal Article
Value-based insurance design bases cost sharing on a medication's clinical value, not its price. This study shows the effectiveness of value-based insurance design.
September 28, 2012 | Program Result
An analysis of the differences in the way 10 health insurance plans in Massachusetts covered the medical costs associated with serious diseases.
October 11, 2011 | Video
This short infographic video explains what cost sharing is and how it changes under health reform.
May 31, 2000 | Program Result
The Group Health Cooperative of Puget Sound, Seattle, assessed the impact of different insurance coverage structures on the utilization and cost effectiveness of smoking-cessation services in a health maintenance organization.
November 1, 2010 | Journal Article
High copayments for medical services can cause patients to underuse essential therapies.
February 1, 2003 | Program Result
The Kaiser Permanente Institute for Health Policy held a discussion on the growing interest in more affordable but less comprehensive health care benefit, plans as a means to maintaining or expanding affordable coverage, and possible policy changes.
January 1, 2001 | Program Result
During the 1980s, expenditures on pharmaceuticals nationwide increased by 152 percent. HMOs implemented a number of cost-control mechanisms to slow the rate of growth of pharmaceutical expenditures, and were successful in doing so compared to fee-for-service health plans.